# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-044671
Filing Date
2018-08-14
Accepted
2018-08-14 16:11:56
Documents
59
Period of Report
2018-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tv499850_10q.htm | 10-Q | 322252
2 | EXHIBIT 10.11 | tv499850_ex10-11.htm | EX-10.11 | 148428
3 | EXHIBIT 10.22 | tv499850_ex10-22.htm | EX-10.22 | 438852
4 | EXHIBIT 10.23 | tv499850_ex10-23.htm | EX-10.23 | 70842
5 | EXHIBIT 10.24 | tv499850_ex10-24.htm | EX-10.24 | 6133
6 | EXHIBIT 10.25 | tv499850_ex10-25.htm | EX-10.25 | 5943
7 | EXHIBIT 31.1 | tv499850_ex31-1.htm | EX-31.1 | 10373
8 | EXHIBIT 32.1 | tv499850_ex32-1.htm | EX-32.1 | 4616
9 | GRAPHIC | tv499850_ex10-22img01.jpg | GRAPHIC | 23027
10 | GRAPHIC | tv499850_ex10-23img02.jpg | GRAPHIC | 2866
11 | GRAPHIC | tv499850_ex10-23img01.jpg | GRAPHIC | 137402
| Complete submission text file | 0001144204-18-044671.txt |  | 4871786

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL INSTANCE DOCUMENT | ttnp-20180630.xml | EX-101.INS | 1161726
13 | XBRL TAXONOMY EXTENSION SCHEMA | ttnp-20180630.xsd | EX-101.SCH | 29431
14 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | ttnp-20180630_cal.xml | EX-101.CAL | 26062
15 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | ttnp-20180630_def.xml | EX-101.DEF | 199329
16 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | ttnp-20180630_lab.xml | EX-101.LAB | 224794
17 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | ttnp-20180630_pre.xml | EX-101.PRE | 224324

Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13341 | Film No.: 181017596
SIC: 2836 Biological Products, (No Diagnostic Substances)